Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01900132 · ClinicalTrials.gov registry record · NA
Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers
A NA study of Motor Neuron Disease and Neuromuscular Disease, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- Recruiting
- Registry status
- NA
- Development phase
- 275
- Enrollment target
- 1
- Study location
NCT01900132 is a NA study of Motor Neuron Disease and Neuromuscular Disease that is actively recruiting participants, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 275 participants, below the 514-participant average among 17 other Motor Neuron Disease trials with a reported enrollment target (46% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01900132, a NA study of Motor Neuron Disease and Neuromuscular Disease, is actively recruiting participants, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- RECRUITING
- Registry status
- NA
- Development phase
- 275 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: \- Electrical impedance myography (EIM) is a new technique being studied to see if it is helpful in evaluating muscle disorders and nerve disorders. EIM looks at how a mild, painless electrical current travels through muscles. Researchers want to gain experience in using the EIM device. They will collect information on the results of using it on people with and without nerve and muscle diseases, and compare that with information from other standard tests. First, they will test the device on healthy people. Then they will test people with a variety of neuromuscular diseases. Because the test is noninvasive and not painful, researchers will test both children and adults. Objectives: \- To gain experience using the EIM muscle testing device. Eligibility: * Healthy volunteers at least 2 years old. * Individuals at least 2 years old who have neuromuscular disease. Design: * Participants will be screened with a medical history and physical exam. * Participants will have one 2-3 hour clinic visit. Researchers may request follow-up visits. * Participants will be tested with the EIM device. The device and small electrodes will be placed on their skin. An electric current will pass through the device, but the participants will not feel this. * Participants may have an ultrasound test. A gel will be put on their skin, and a device will be moved over the skin. * Participants may have a nerve test. Electrodes will be placed on their skin, and they will feel a small shock. * Participants may have a test where a thin needle is inserted in their muscle.
Conditions Studied
Interventions
- DEVICE EIM testing
- DEVICE Nerve & muscle ultrasonography
- DEVICE Nerve conduction studies
- DEVICE Electromyography (EMG)
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 275 participants |
| Start Date | 2013-06-20 |
| Est. Completion | 2026-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01900132
The ClinicalTrials.gov registry entry for NCT01900132 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 275 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 514-participant average among 17 other Motor Neuron Disease trials with a reported enrollment target (46% lower). The listed sponsor is National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Motor Neuron Disease appearing as the primary indexed condition, and to 4 interventions - of which EIM testing is the first listed.
NCT01900132 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT01900132 about?
NCT01900132 is a clinical study titled "Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers". Background: \- Electrical impedance myography (EIM) is a new technique being studied to see if it is helpful in evaluating muscle disorders and nerve disorders. EIM looks at how a mild, painless electrical current travels through muscles. Researchers want to gain experience in using the EIM device....
What is the current status of trial NCT01900132?
This trial is currently recruiting. It is a NA study. The enrollment target is 275 participants. The study started on 2013-06-20. Estimated completion is 2026-06-01.
What conditions does trial NCT01900132 study?
This clinical trial studies the following conditions: Motor Neuron Disease, Neuromuscular Disease, Inherited Neuromuscular Conditions, Inherited Neuropathies.
What interventions are being tested in trial NCT01900132?
The interventions under investigation include: EIM testing (DEVICE), Nerve & muscle ultrasonography (DEVICE), Nerve conduction studies (DEVICE), Electromyography (EMG) (DEVICE).
Who is sponsoring clinical trial NCT01900132?
This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01900132 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Motor Neuron Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Non-invasive BCI-controlled Assistive Devices
RECRUITING · NA
-
Novel MRI Biomarkers for Monitoring Disease Progression in ALS
RECRUITING
-
Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)
RECRUITING
-
Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures
RECRUITING
-
Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)
RECRUITING
-
Study of Inherited Neurological Disorders
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.